glp-1 and migraines New findings show a link between use a lower risk of severe GLP-1 Drugs Could Dramatically Reduce

Track your protocol: If you are using retatrutide under medical supervision, use this chart to track your current dose and upcoming escalations

It found that these drugs may slightly increase the chance of getting gallstones (cholelithiasis) and acid reflux (GERD)

This can not only help make better food choices, but it also supports steady energy throughout the day

Strategic use of dietary fibre can help mitigate these symptoms and improve treatment tolerability, though the approach must be tailored to the specific digestive complaint

Semaglutide (Wegovy) works by targeting one receptor to help control appetite and blood sugar, while Tirzepatide (Mounjaro) targets two receptors, which can lead to potentially greater weight loss results in some patients

The drugs are also effective in promoting weight loss if taken according to their treatment plan, which means patients should take the drugs continuously for at least 12 weeks